← Back to Search
Contemporary Approach To The Diagnosis Of Malignant Pleural Effusion.
V. Kaul, D. McCracken, N. Rahman, O. Epelbaum
Published 2019 · Medicine
Download PDFAnalyze on Scholarcy
Advanced malignancy is a prevalent cause of exudative pleural effusion. The management of malignant pleural effusion (MPE) has been the subject of several recent randomized controlled trials and excellent reviews. Less attention has been focused on another controversial and challenging aspect of MPE: it's diagnosis. Prior to selecting the optimal management strategy, the presence of an MPE must first be correctly identified with an emphasis on minimizing invasiveness and discomfort in a patient afflicted with late-stage cancer. The aim of the present review is to summarize the current knowledge about MPE diagnostics and to propose an algorithm for the diagnosis of MPE in established or suspected malignancy.
This paper references
Efficacy and Cost of Awake Thoracoscopy and Video-Assisted Thoracoscopic Surgery in the Undiagnosed Pleural Effusion.
Christine M. McDonald (2018)
Clinical features and survival of lung cancer patients with pleural effusions
J. M. Porcel (2015)
Usefulness of MR signal intensity in distinguishing benign from malignant pleural disease.
F. Falaschi (1996)
Biomarkers in the diagnosis of pleural diseases: a 2018 update
J. M. Porcel (2018)
Detection of Cancer DNA in Plasma of Patients with Early-Stage Breast Cancer
Julia A. Beaver (2014)
Prospective study to determine the volume of pleural fluid required to diagnose malignancy.
J. Swiderek (2010)
The impact of thoracoscopy on the management of pleural disease.
R. J. Harris (1995)
Physician-based ultrasound-guided biopsy for diagnosing pleural disease.
R. Hallifax (2014)
Diagnosis of pleural effusions. Experience with clinical studies, 1986 to 1990.
M. Marel (1995)
Comparison of needle biopsy with cytologic analysis for the evaluation of pleural effusion: analysis of 414 cases.
U. Prakash (1985)
The utility of ultrasound-guided thoracentesis and pleural biopsy in undiagnosed pleural exudates
C. F. Koegelenberg (2015)
Development and validation of response markers to predict survival and pleurodesis success in patients with malignant pleural effusion (PROMISE): a multicohort analysis.
I. Psallidas (2018)
Medical thoracoscopy vs CT scan-guided Abrams pleural needle biopsy for diagnosis of patients with pleural effusions: a randomized, controlled trial.
M. Metintas (2010)
Accuracy of fluorodeoxyglucose-PET imaging for differentiating benign from malignant pleural effusions: a meta-analysis.
J. M. Porcel (2015)
Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions.
J. M. Porcel (2004)
Non‐specific pleuritis in patients with active malignancy
Erik Vakil (2018)
High-throughput screening of rare metabolically active tumor cells in pleural effusion and peripheral blood of lung cancer patients
Yin Tang (2017)
Thoracic ultrasound in the diagnosis of malignant pleural effusion
N. R. Qureshi (2008)
Investigating unilateral pleural effusions: the role of cytology
D. Arnold (2018)
Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer
J. Tie (2016)
Predicting malignant and tuberculous pleural effusions through demographics and pleural fluid analysis of patients
L. Valdés (2015)
The diagnostic accuracy of pleural effusion and plasma samples versus tumour tissue for detection of EGFR mutation in patients with advanced non-small cell lung cancer: comparison of methodologies
Xiaoqing Liu (2013)
Feasibility and safety of parietal pleural cryobiopsy during semi‐rigid thoracoscopy
A. Rozman (2016)
Prevalence and Etiology of Pleural Effusions in Hospitalized Patients: An Analysis of HCUP-NIS 2012
N. Taghizadeh (2017)
Postoperative pain and quality of life after lobectomy via video-assisted thoracoscopic surgery or anterolateral thoracotomy for early stage lung cancer: a randomised controlled trial.
Morten Bendixen (2016)
The Role of 18F-FDG PET/CT Integrated Imaging in Distinguishing Malignant from Benign Pleural Effusion
Yajuan Sun (2016)
The value of narrow band imaging in diagnosis of head and neck cancer: a meta-analysis
H. Zhou (2017)
Vascular Endothelial Growth Factor in Plasma and Pleural Effusion Is a Biomarker for Outcome After Bevacizumab plus Carboplatin-Paclitaxel Treatment for Non-small Cell Lung Cancer with Malignant Pleural Effusion.
M. Tamiya (2016)
Role of CT in assessing pleural malignancy prior to thoracoscopy
R. J. Hallifax (2014)
Outcome of patients with nonspecific pleuritis/fibrosis on thoracoscopic pleural biopsies.
H. E. Davies (2010)
Thoracoscopic evaluation of 129 cases having undiagnosed exudative pleural effusions
C. B. Patil (2016)
A prospective study of the volume of pleural fluid required for accurate diagnosis of malignant pleural effusion.
W. Abouzgheib (2009)
Standard pleural biopsy versus CT-guided cutting-needle biopsy for diagnosis of malignant disease in pleural effusions: a randomised controlled trial
N. Maskell (2003)
The diagnosis of malignant mesothelioma in effusion cytology
A. Paintal (2013)
Pleural fluid pH in malignant effusions. Diagnostic, prognostic, and therapeutic implications.
S. Sahn (1988)
THE CASE FOR EXFOLIATIVE CYTOLOGY OF SEROUS EFFUSIONS.
B. Naylor (1964)
Local anaesthetic thoracoscopy: British Thoracic Society pleural disease guideline 2010
N. Rahman (2010)
CT Scan-Guided Abrams' Needle Pleural Biopsy versus Ultrasound-Assisted Cutting Needle Pleural Biopsy for Diagnosis in Patients with Pleural Effusion: A Randomized, Controlled Trial
M. Metintas (2016)
A minimum fluid volume of 75 mL is needed to ensure adequacy in a pleural effusion: A retrospective analysis of 2540 cases
Lisa M. Rooper (2014)
Thoracoscopy in undiagnosed pleural effusions.
M. D. de Groot (1998)
Assessment of EGFR Mutation Status in Matched Plasma and Tumor Tissue of NSCLC Patients from a Phase I Study of Rociletinib (CO-1686)
C. Karlovich (2016)
Vascular endothelial growth factor in pleural fluid for differential diagnosis of benign and malignant origin and its clinical applications.
A. Fiorelli (2011)
Malignant pleural disease: diagnosis by using diffusion-weighted and dynamic contrast-enhanced MR imaging--initial experience.
J. Coolen (2012)
Predictors of pleural malignancy in patients with pleural effusion undergoing thoracoscopy.
J. Ferrer (2005)
Malignant pleural mesothelioma: role of CT, MRI, and PET/CT in staging evaluation and treatment considerations.
M. Truong (2013)
Carcinomatous involvement of the pleura: an analysis of 96 patients.
B. Chernow (1977)
Narrow Band Imaging Applied to Pleuroscopy for the Assessment of Vascular Patterns of the Pleura
A. Ishida (2009)
Feasibility and safety of outpatient medical thoracoscopy at a large tertiary medical center: a collaborative medical-surgical initiative.
Z. Depew (2014)
CT in differential diagnosis of diffuse pleural disease.
A. Leung (1990)
Thoracoscopy in pleural malignant mesothelioma: A prospective study of 188 consecutive patients. Part 1: Diagnosis
C. Boutin (1993)
Diagnostic efficacy of pleural biopsy as compared with that of pleural fluid examination.
K. Nance (1991)
The comparative accuracy of different pleural biopsy techniques in the diagnosis of malignant mesothelioma
R. Attanoos (2008)
A Randomized Trial Comparing the Diagnostic Yield of Rigid and Semirigid Thoracoscopy in Undiagnosed Pleural Effusions
S. Dhooria (2014)
Closed pleural biopsy to diagnose mesothelioma: dead or alive?
K. McLaughlin (2009)
Etiology and pleural fluid characteristics of large and massive effusions.
J. M. Porcel (2003)
Utilidad de la medición de CEA y CA 15-3 en los exudados pleurales no purulentos para diagnosticar malignidad: experiencia de un único centro
J. M. Porcel (2017)
Predicting survival in malignant pleural effusion: development and validation of the LENT prognostic score
A. Clive (2014)
Integrating liquid biopsies into the management of cancer
G. Siravegna (2017)
Utility of contrast-enhanced ultrasound with SonoVue in biopsy of small subpleural nodules.
Jinlin Wang (2015)
Clinically important factors influencing the diagnostic measurement of pleural fluid pH and glucose.
N. Rahman (2008)
Medical thoracoscopy and its evolving role in the diagnosis and treatment of pleural disease.
Vivek Murthy (2017)
Identifying Malignant Pleural Effusion by A Cancer Ratio (Serum LDH: Pleural Fluid ADA Ratio)
A. Verma (2015)
Etiología del derrame pleural: análisis de más de 3.000 toracocentesis consecutivas
J. M. Porcel (2014)
Phylogenetic ctDNA analysis depicts early stage lung cancer evolution
C. Abbosh (2017)
Derivation and validation of a CT scan scoring system for discriminating malignant from benign pleural effusions.
J. M. Porcel (2015)
Clinical impact and reliability of pleural fluid mesothelin in undiagnosed pleural effusions.
H. E. Davies (2009)
This paper is referenced by
Number of mesothelial cells as a measure of adequacy criteria for pleural effusions: A multi‐institutional study
Erika F. Rodriguez (2020)
Pulmonary MRI: Applications and Use Cases
Raza Mushtaq (2020)